On October 18, 2021 Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, reported that it has through its fully owned subsidiary Mentice Inc entered into an agreement with ABBOTT Inc. to provide simulation solutions for training of interventional devices.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The order covers systems that will be offered under a rental agreement for a 12-month term and the company will accordingly account for revenue under the same period.

The solutions will support ABBOTT’s CRM division in the work of rolling out new medical devices to the market in a safe and effective way.

The order will be accounted for in the order book for the segment Medical Device Industry during the fourth quarter 2021. The total value for the order amounts to SEK 7.0 million.